CHARACTERIZATION OF N-ACETYLNEURAMINIC ACID HYDROXYLASE
Project Number5R29GM043165-02
Contact PI/Project LeaderMUCHMORE, ELAINE ANSELMO
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN DIEGO
Description
Abstract Text
In recent years, many examples of cell surface carbohydrates which have
important biological functions have been described. These include
recognition by antibodies, binding of viruses. bacterial capsular
antigenicity and regulation of growth. Sialic acids, which are often the
terminal carbohydrate moieties on cell surface glycoproteins and
glycolipids, are in a unique position to have effects on biological
functions. O-acetylated sialic acid modification, N-glycolyl neuraminic
aced (Neu5Gc), has been found in both fetal human tissue and in an
increasing number of human tumors. Because its introduction to a normal
adult human results in an intense immunogenic response, it is a true onco-
fetal antigen. The role which Neu5Gc plays in normal cellular events is
not known, nor is its role in malignant transformation understood.
Neu5Gc is converted from N-acetyl neuraminic acid by the enzyme N-
acetylneuraminic mono-oxygenase. Detailed enzyme kinetics have not been
done, nor has this enzyme ever been isolated and purified.
The goal of this project is to isolate and purify the mono-oxygenase by
conventional and affinity chromotography. The kinetics and properties of
the isolated enzyme will be determined. Antibodies to the purified
protein will be generated so that an immunoassay can be developed. The
immunoassay will be used for three major areas of investigation. First,
it will be used to correlate enzyme expression with expression of Neu5Gc
in the rat colon, a tissue which has developmentally-regulated changes in
expression of Neu5Gc. Second, the precise subcellular location of the
enzyme will be determined. Third, the cellular regulation of enzyme
expression can be determined. The purified enzyme will also be used to
determine the structural and kinetic properties of the protein. In the
long run, oligonucleotide probes from peptide sequences or antibodies will
be used to clone the gene encoding the enzyme. Ultimately, the goal is to
understand the normal fetal expression and malignant re-expression of
Neu5Gc by correlation with activity and presence of the converting enzyme
at the gene, message, and activity levels.
No Sub Projects information available for 5R29GM043165-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29GM043165-02
Patents
No Patents information available for 5R29GM043165-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29GM043165-02
Clinical Studies
No Clinical Studies information available for 5R29GM043165-02
News and More
Related News Releases
No news release information available for 5R29GM043165-02
History
No Historical information available for 5R29GM043165-02
Similar Projects
No Similar Projects information available for 5R29GM043165-02